Leveraging APAC partnerships to de-risk clinical trials

Demand for APAC clinical trials is still on the rise as COVID numbers continue to fall across the region attracting biotechs wanting to restart stalled or paused clinical trials from around the globe. Indeed Australia recorded zero new cases in the past 25 days.

Find out why industry partnerships matter in the APAC region. The relationships biotechs need to streamline the clinical process and take advantage of the exceptional start-up timeframes on offer. Discover how to check that your clinical partners have the right relationship credentials and alliances. Most importantly learn how to avoid a trial rescue crisis by ensuring you are working with a connected network of industry leaders.

watch now
Watch the webinar on demand
Julia Jones

Julia Jones

VP Business Development, Agilex Biolabs

With 30 years of industry experience, Julia is a highly respected specialist in the business of drug development, across clinical trials and associated bioanalytical services.

Julia has specialized in global CRO clinical trials business development with some of the leading regional and internal CROs, and has extensive knowledge of the success requirements of biotechs and pharma in the US, Asia, and EU.

Julia is committed to driving excellence in bioanalytical services. Julia is aligned with the Agilex Biolabs scientific team, as well as key industry partners, to support successful clinical outcomes.

Kurt Sales

Kurt J. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, PGCM)

Principal Investigator Nucleus Network

Dr Kurt Sales has over 20 years of experience in a career spanning research and development, research management and business development in the UK and South Africa. At Agilex Biolabs, Kurt is responsible for management and oversight of the Agilex Biolabs Immunoassay division.

Kurt has extensive expertise in pre-clinical and clinical assay development, cellular and molecular biology, molecular signaling, flow cytometry, cell-based models and biomarkers, notably in the areas of inflammation and immunology. He also has extensive experience ensuring strict GLP compliance for bioanalytical assays and preclinical safety testing through PK/PD/Biomarker assays.

Widely published with 45 peer-reviewed scientific papers in high impact journals, a book chapter and presentations at over 30 conferences, Kurt also received the prestigious Society for Reproduction and Fertility New Investigator Award.

Kurt has a Ph.D. in Medical Biochemistry, a Masters in Biochemistry, and Bachelors of Science in Medicine with Honours in Pharmacology and a Bachelor of Science in Biochemistry and Physiology. He has a Diploma in Business Organisation and Management and a Post Graduate Certificate in Management.

Arsalan Arif

arsalan arif

Founder & CEO, Endpoints News

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.